Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

DFNB49 is an important cause of non-syndromic deafness in Czech Roma patients but not in the general Czech population

D. Šafka Brožková, J. Laštůvková, H. Štěpánková, M. Krůtová, M. Trková, P. Myška, P. Seeman

. 2012 ; 82 (6) : 579-582.

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024486

Grantová podpora
NS10552 MZ0 CEP - Centrální evidence projektů

Due to endogamy, the Roma have a higher risk for autosomal recessive (AR) disorders. We used homozygosity mapping on single-nucleotide polymorphism chips in one Czech Roma consanguineous family with non-syndromic hearing loss (NSHL). The second largest homozygous region in a deaf patient was mapped to the previously reported DFNB49 region. The MARVELD2 gene was recently reported as a causal gene for NSHL DFNB49. Sequencing of the MARVELD2 gene revealed a previously reported homozygous mutation c.1331+2 T>C (IVS4 + 2 T>C) in the deaf child. Subsequently, the same mutation was found in two more Roma families from an additional 19 unrelated Czech Roma patients with deafness tested for the MARVELD2 gene. To explore the importance of MARVELD2 mutations and DFNB49 for the general Czech and Central European population with early hearing loss we also tested 40 unrelated Czech patients with AR NSHL. No pathogenic mutation in the MARVELD2 gene was found in a group of 40 Czech non-Roma patients. Mutations in the MARVELD2 gene seem to be a significant cause of early NSHL in Czech Roma and this gene should be tested in this group of patients after GJB2.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13024486
003      
CZ-PrNML
005      
20200129095634.0
007      
ta
008      
130703s2012 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/j.1399-0004.2011.01817.x $2 doi
035    __
$a (PubMed)22097895
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Šafka Brožková, D. $u DNA Laboratory, Department of Child Neurology, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic. dana.brozkova@seznam.cz
245    10
$a DFNB49 is an important cause of non-syndromic deafness in Czech Roma patients but not in the general Czech population / $c D. Šafka Brožková, J. Laštůvková, H. Štěpánková, M. Krůtová, M. Trková, P. Myška, P. Seeman
520    9_
$a Due to endogamy, the Roma have a higher risk for autosomal recessive (AR) disorders. We used homozygosity mapping on single-nucleotide polymorphism chips in one Czech Roma consanguineous family with non-syndromic hearing loss (NSHL). The second largest homozygous region in a deaf patient was mapped to the previously reported DFNB49 region. The MARVELD2 gene was recently reported as a causal gene for NSHL DFNB49. Sequencing of the MARVELD2 gene revealed a previously reported homozygous mutation c.1331+2 T>C (IVS4 + 2 T>C) in the deaf child. Subsequently, the same mutation was found in two more Roma families from an additional 19 unrelated Czech Roma patients with deafness tested for the MARVELD2 gene. To explore the importance of MARVELD2 mutations and DFNB49 for the general Czech and Central European population with early hearing loss we also tested 40 unrelated Czech patients with AR NSHL. No pathogenic mutation in the MARVELD2 gene was found in a group of 40 Czech non-Roma patients. Mutations in the MARVELD2 gene seem to be a significant cause of early NSHL in Czech Roma and this gene should be tested in this group of patients after GJB2.
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a hluchota $x genetika $x patologie $7 D003638
650    _2
$a etnicita $x genetika $7 D005006
650    _2
$a geny recesivní $x genetika $7 D005808
650    _2
$a homozygot $7 D006720
650    _2
$a lidé $7 D006801
650    _2
$a MARVELD2 protein $x genetika $7 D062794
650    _2
$a jednonukleotidový polymorfismus $x genetika $7 D020641
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Laštůvková, J. $u Department of Medical Genetics, Masaryk Hospital, Regional Health Corporation, Ústí nad Labem, Czech Republic
700    1_
$a Štěpánková, Helena $7 xx0244385 $u Department of Clinical Genetics, Hospital České Budějovice, České Budějovice, Czech Republic
700    1_
$a Krůtová, M. $u DNA Laboratory, Department of Child Neurology, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic
700    1_
$a Trková, M. $u Centre for Medical Genetics and Reproductive Medicine GENNET, Prague, Czech Republic
700    1_
$a Myška, P. $u Department of Otorhinolaryngology, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic
700    1_
$a Seeman, P. $u DNA Laboratory, Department of Child Neurology, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic
773    0_
$w MED00001127 $t Clinical genetics $x 1399-0004 $g Roč. 82, č. 6 (2012), s. 579-582
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22097895 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20200129100016 $b ABA008
999    __
$a ok $b bmc $g 988166 $s 822866
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 82 $c 6 $d 579-582 $i 1399-0004 $m Clinical genetics $n Clin Genet $x MED00001127
GRA    __
$a NS10552 $p MZ0
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...